Published in Health Business Week, October 13th, 2006
Arthur Mandell was elected to MaxCyte's board of directors, Judith Hedstrom joined the executive team in the new role of senior vice president, corporate and business development, and Carl June, MD, became a member of MaxCyte's roster of scientific and medical advisors.
Mandell joined Prestwick Pharmaceuticals in November 2005 as president and COO and currently serves as executive strategic advisor. Mandell has also served as a director of the company since...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.